Kythera Biopharmaceuticals

About:

Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.

Website: http://www.kytherabiopharma.com

Twitter/X: kytherabiopharm

Top Investors: ARCH Venture Partners, Invus, Versant Ventures, Latham & Watkins, Wilson Sonsini Goodrich & Rosati

Description:

KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California. KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.